In order to mimic an immunosuppressive environment, we assessed the functionality of our BiMAb in co-cultures of tumor cells with CD3+ T cells and titrated amounts of exogenous IL-10 and TGF-β. The gene discussed is TGFB1; the disease is neoplasm.